ACTIP objectives and scope

ACTIP is an independent and informal, science-based forum of European companies with an active interest in the use of animal cell technology in the development and production of biopharmaceuticals, vaccines and other preventative or therapeutic approaches.

Its objectives are:

• networking among the member companies, with SMEs working in the field and with academics, notably those working on research projects sponsored by the European Commission;
• following new developments in R&D;
• maintaining a focus on mammalian cell technology;

For purposes of definition, mammalian cell technology is considered to include animal cells, human cells, primary cells, insect cells and stem cells.
New developments in other cell types are reported on regularly.

ACTIP’s focus is primarily industrial, although very good relations are maintained with academics and non-member SMEs working in the field (see also ’interesting links´).

As discussed and agreed on December 2004, Antwerp